ArticleBulletin of experimental biology and medicine2025
Comparative Analysis of Quantitative Indicators of Progesterone Receptor Protein and mRNA Expression in Tumor Cell Lines.
Article in Bulletin of experimental biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progesterone receptors are involved in the regulation of tumor cell proliferation and therefore can be considered as a target of antitumor drugs. However, the question of the concordance of quantitative indicators of the protein and mRNA produced as a result of the expression of a single gene remains open. In this study, the concordance of the expression of the progesterone receptor protein and mRNA was evaluated using real-time PCR and flow cytometry, respectively, in 10 tumor cell lines (T47D, A375, PANC-1, SNU-1, HT-29, OVCAR-3, BXPC-3, HCC1954, A549, MCF-7). The expression of the progesterone receptor protein was detected in all studied cell lines; the expression of progesterone receptor mRNA was detected only in the T47D, which shows the discordance of these indicators and queries the relevance of measuring the expression of tumor marker mRNA when selecting the targeted anti-tumor drugs for the treatment of oncological diseases.
Indexed as
Identifiers
40682653What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.